top of page
Afrezza® inhaled insulin is approved for diabetes management
In the 2nd week of December 2024, the medical fraternity received a piece of heart-warming news about inhaled insulin. Cipla received approval for the distribution and marketing of Afrezza® an inhaled insulin in India. The product created by Mannkind Corporation can be a blessing for millions of Indians who have compliance issues with injectable insulin (1). About Afrezza® Afrezza® (inhalable insulin) is a promising, ultra-rapid-acting noninjectable insulin delivery option de
Dr. Sheeba Rani
Sep 9, 20254 min read
bottom of page